Literature DB >> 11326821

Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.

M Badri1, R Ehrlich, R Wood, T Pulerwitz, G Maartens.   

Abstract

SETTING: Adult human immunodeficiency virus (HIV) clinics affiliated to the University of Cape Town, South Africa.
OBJECTIVE: To assess the impact of tuberculosis on HIV-1 disease progression in an area with high tuberculosis prevalence and minimal antiretroviral therapy use.
DESIGN: Prospective patient cohort study.
METHODS: Age, race, risk status, CD4+ T-lymphocyte count, history of AIDS, prophylactic co-trimoxazole and antiretroviral therapy were controlled for in a time-dependent Cox proportional hazards regression model.
RESULTS: Tuberculosis fulfilling the case definition developed in 158/609 patients in the 5-year observation period. Tuberculosis was associated with an increased risk of AIDS (adjusted risk ratio [RR] = 1.60, 95% confidence interval [CI] 1.08-2.41; P = 0.02) and death (adjusted RR = 2.16, 95% CI 1.29-3.59; P = 0.003). In a stratified analysis, the increased mortality associated with tuberculosis was observed only in patients with CD4+ T-lymphocyte count > 200 cells/microliter and in those without AIDS at baseline.
CONCLUSION: The onset of tuberculosis in HIV-infected patients is associated with an increased risk of AIDS and death. Although a causal link cannot be established in an observational study, our findings support the view that prolonged immune activation induced by tuberculosis leads to prolonged increased HIV replication and consequent accelerated disease progression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11326821

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  47 in total

Review 1.  Tuberculosis and HIV Coinfection.

Authors:  Judith Bruchfeld; Margarida Correia-Neves; Gunilla Källenius
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

2.  Outcomes in HIV-infected adults with tuberculosis at clinics with and without co-located HIV clinics in Botswana.

Authors:  A B Schwartz; N Tamuhla; A P Steenhoff; K Nkakana; R Letlhogile; T R Chadborn; M Kestler; N M Zetola; S Ravimohan; G P Bisson
Journal:  Int J Tuberc Lung Dis       Date:  2013-10       Impact factor: 2.373

3.  Mortality associated with tuberculosis/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa.

Authors:  Tiyani E Mabunda; Nalezani J Ramalivhana; Yoswa M Dambisya
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

4.  Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

Authors:  Harriet Mayanja-Kizza; Edward Jones-Lopez; Alphonse Okwera; Robert S Wallis; Jerrold J Ellner; Roy D Mugerwa; Christopher C Whalen
Journal:  J Infect Dis       Date:  2005-02-08       Impact factor: 5.226

5.  Multidrug-Resistant Tuberculosis in Patients with Human Immunodeficiency Virus. Management Considerations within High-resourced Settings.

Authors:  John W Wilson; Diana M Nilsen; Suzanne M Marks
Journal:  Ann Am Thorac Soc       Date:  2020-01

6.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

7.  Death rates from human immunodeficiency virus and tuberculosis among American Indians/Alaska Natives in the United States, 1990-2009.

Authors:  Brigg Reilley; Emily Bloss; Kathy K Byrd; Jonathan Iralu; Lisa Neel; James Cheek
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

8.  Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals.

Authors:  Macarthur Charles; Francine Noel; Paul Leger; Patrice Severe; Cynthia Riviere; Carole Anne Beauharnais; Erica Miller; John Rutledge; Heejung Bang; Wesley Shealey; Richard T D'Aquila; Roy M Gulick; Warren D Johnson; Peter F Wright; Jean William Pape; Daniel W Fitzgerald
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

9.  Increased mortality associated with treated active tuberculosis in HIV-infected adults in Tanzania.

Authors:  Conrad Kabali; Lillian Mtei; Daniel R Brooks; Richard Waddell; Muhammad Bakari; Mecky Matee; Robert D Arbeit; Kisali Pallangyo; C Fordham von Reyn; C Robert Horsburgh
Journal:  Tuberculosis (Edinb)       Date:  2013-03-22       Impact factor: 3.131

10.  Immune Response and Mortality Risk Relate to Distinct Lung Microbiomes in Patients with HIV and Pneumonia.

Authors:  Meera K Shenoy; Shoko Iwai; Din L Lin; William Worodria; Irene Ayakaka; Patrick Byanyima; Sylvia Kaswabuli; Serena Fong; Stephen Stone; Emily Chang; J Lucian Davis; Ali Ahmad Faruqi; Mark R Segal; Laurence Huang; Susan V Lynch
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.